Skip to main content
VCbacked
Log inGet Started

Archon Biosciences

Washington, United States

Archon is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.

$20.0M raised
Oct 2024
Seed
BiotechnologyTherapeutics

Top Investors

MadronaAlexandria Venture InvestmentsPack VenturesDUMACSahsen Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Archon Biosciences

How much funding has Archon Biosciences raised?
Archon Biosciences has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Who are Archon Biosciences's investors?
Archon Biosciences's investors include Madrona, Alexandria Venture Investments, Pack Ventures, DUMAC, Sahsen Ventures.
Where is Archon Biosciences headquartered?
Archon Biosciences is headquartered in Washington, United States.
What does Archon Biosciences do?
Archon is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
What stage is Archon Biosciences at?
Archon Biosciences is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Archon Biosciences — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/archon-biosciences. Accessed June 17, 2026.
APA
VCBacked. (2024). Archon Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/archon-biosciences
Wikipedia (cite web)
{{cite web |title=Archon Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/archon-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong